Politics and Government Politics and Government
Wed, November 27, 2024
Tue, November 26, 2024
[ Tue, Nov 26th 2024 ] - Brian Stokes
Trust Matters in Cabinet Picks
Mon, November 25, 2024
Sun, November 24, 2024
Thu, November 14, 2024
Tue, November 12, 2024
Thu, April 23, 2009
Mon, February 2, 2009
[ Mon, Feb 02nd 2009 ] - Nathan Burkes
Is Obama a rock star?
Fri, January 30, 2009

Oncothyreon Announces Full Year and Fourth Quarter 2011 Financial Results Conference Call


Published on 2012-02-28 05:15:30 - Market Wire
  Print publication without navigation


Oncothyreon Announces Full Year and Fourth Quarter 2011 Financial Results Conference Call

Oncothyreon Announces Full Year and Fourth Quarter 2011 Financial Results Conference Call

[ ]

SEATTLE, Feb. 28, 2012 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: [ ONTY ]) today announced that it will conduct a conference call to discuss its full year and fourth quarter 2011 financial results and provide a review of its pipeline of products in development on Tuesday, March 6, 2012 at 4:30 p.m. Eastern Time.

To participate in the call by telephone, please dial (877) 280-7291 (United States) or (707) 287-9361 (International). In addition, the call will be webcast live and can be accessed on the "Events" page of the "News & Events" section of Oncothyreon's website at [ www.oncothyreon.com ]. An archive of the webcast will be available after completion of the discussion and will be posted on the Oncothyreon website.

About Oncothyreon

Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit [ www.oncothyreon.com ].

SOURCE Oncothyreon Inc.

[ Back to top ]


Publication Contributing Sources